Journal of Biological Chemistry · 2013 · 57 citations · 60 references
MedicineNeurobiologyNeuroscienceCellular NeuroscienceMolecular NeurobiologyMolecular NeuroscienceCellular Responses To HypoxiaHypoxic-ischemic Brain InjuryHypoxic-ischemic EncephalopathyNeuroprotectionCerebral Hypoxic-ischemic InjuryHypoxic Neuronal InjuryNeonatal Brain IschemiaNeonatal HypoxiaNeonatal Hypoxic-ischemic EncephalopathyNeuroprotective MechanismsNeuroprotective ResponsesProtein Expression Levels
This study was designed to investigate the expression profile of CYGB, its potential neuroprotective function, and underlying molecular mechanisms using a model of neonatal hypoxia-ischemia (HI) brain injury. Cygb mRNA and protein expression were evaluated within the first 36 h after the HI model was induced using RT-PCR and Western blotting. Cygb mRNA expression was increased at 18 h in a time-dependent manner, and its level of protein expression increased progressively in 24 h. To verify the neuroprotective effect of CYGB, a gene transfection technique was employed. Cygb cDNA and shRNA delivery adenovirus systems were established ( Cygb -cDNA-ADV and Cygb -shRNA-ADV, respectively) and injected into the brains of 3-day-old rats 4 days before they were induced with HI treatment. Rats from different groups were euthanized 24 h post-HI, and brain samples were harvested. 2,3,5-Triphenyltetrazolium chloride, TUNEL, and Nissl staining indicated that an up-regulation of CYGB resulted in reduced acute brain injury. The superoxide dismutase level was found to be dependent on expression of CYGB. The Morris water maze test in 28-day-old rats demonstrated that CYGB expression was associated with improvement of long term cognitive impairment. Studies also demonstrated that CYGB can up-regulate mRNA and protein levels of VEGF and increase both the density and diameter of the microvessels but inhibits activation of caspase-2 and -3. Thus, this is the first in vivo study focusing on the neuroprotective role of CYGB. The reduction of neonatal HI injury by CYGB may be due in part to antioxidant and antiapoptotic mechanisms and by promoting angiogenesis. Background: Potential functions of cytoglobin (CYGB) in neonatal hypoxia-ischemia (HI) brain injury have not been reported. Results: Up-regulation of CYGB reduces HI injury and improves long term cognitive impairment after neonatal HI. Conclusion: CYGB exhibits neuroprotective effects, possibly through antioxidant and antiapoptotic functions as well as by stimulating angiogenesis. Significance: These results provide a novel target for developing a clinically relevant strategy for future studies.
60
Moderate Hypothermia to Treat Perinatal Asphyxial Encephalopathy
Denis Azzopardi, Brenda Strohm, A. David Edwards et al. · New England Journal of Medicine · 2009 · 1.7K citations
VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain
Zheng Gang Zhang, Li Zhang, Quan Jiang et al. · Journal of Clinical Investigation · 2000 · 1.3K citations · Full text
Medicine, Neurology, Neuroscience +16
VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia
Yunjuan Sun, Kunlin Jin, Lin Xie et al. · Journal of Clinical Investigation · 2003 · 1.1K citations · Full text
Medicine, Neurobiology, Neuroscience +17